Cecha
Specific learning disability
Impairment of certain skills such as reading or writing, coordination, self-control, or attention that interfere with the ability to learn. The impairment is not related to a global deficiency of intelligence.
Podsumowanie
- Układ organizmu
- Abnormality of the nervous system
Genom referencyjnyGRCh38hg38
Pozycje na stronach genów i wariantów zależą od tego wyboru, w tej przeglądarce.
Read the genes linked to Specific learning disability, and the rest of your genome, with one test.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni
Zamawiam Genome Test298 genów powiązanych z Specific learning disability
Zmiany w tych genach powodują rzadkie choroby, w których występuje Specific learning disability. Większość osób z tą cechą nie ma żadnej z tych chorób, a gen z tej listy nic nie mówi o czyimkolwiek własnym genomie.
| Gen | Jak często występuje | Choroby |
|---|---|---|
| FARSBphenylalanyl-tRNA synthetase subunit beta | Zawsze | W 1 chorobie |
| ITPR1inositol 1,4,5-trisphosphate receptor type 1 | Zawsze | W 1 chorobie |
| MICU1mitochondrial calcium uptake 1 | Zawsze | W 1 chorobie |
| PAPPA2pappalysin 2 | Zawsze | W 1 chorobie |
| PCGF2polycomb group ring finger 2 | Zawsze | W 1 chorobie |
| SKOR2SKI family transcriptional corepressor 2 | Zawsze | W 1 chorobie |
| SRSF1serine and arginine rich splicing factor 1 | Zawsze | W 1 chorobie |
| TMEM94transmembrane protein 94 | Zawsze | W 1 chorobie |
| ACTBactin beta | Bardzo często (80–99%) | W 1 chorobie |
| ACTG1actin gamma 1 | Bardzo często (80–99%) | W 1 chorobie |
| ATP7AATPase copper transporting alpha | Bardzo często (80–99%) | W 1 chorobie |
| B3GALNT2beta-1,3-N-acetylgalactosaminyltransferase 2 | Bardzo często (80–99%) | W 1 chorobie |
| B4GAT1beta-1,4-glucuronyltransferase 1 | Bardzo często (80–99%) | W 1 chorobie |
| CKAP2Lcytoskeleton associated protein 2L | Bardzo często (80–99%) | W 1 chorobie |
| COL4A1collagen type IV alpha 1 chain | Bardzo często (80–99%) | W 1 chorobie |
| CRPPACDP-L-ribitol pyrophosphorylase A | Bardzo często (80–99%) | W 1 chorobie |
| DAG1dystroglycan 1 | Bardzo często (80–99%) | W 1 chorobie |
| DIS3L2DIS3 like 3'-5' exoribonuclease 2 | Bardzo często (80–99%) | W 1 chorobie |
| DMDdystrophin | Bardzo często (80–99%) | W 1 chorobie |
| EBF3EBF transcription factor 3 | Bardzo często (80–99%) | W 1 chorobie |
| EHMT1euchromatic histone lysine methyltransferase 1 | Bardzo często (80–99%) | W 1 chorobie |
| FKRPfukutin related protein | Bardzo często (80–99%) | W 1 chorobie |
| FKTNfukutin | Bardzo często (80–99%) | W 1 chorobie |
| HERC2HECT and RLD domain containing E3 ubiquitin protein ligase 2 | Bardzo często (80–99%) | W 1 chorobie |
| HMGA2high mobility group AT-hook 2 | Bardzo często (80–99%) | W 1 chorobie |
| KAT6Blysine acetyltransferase 6B | Bardzo często (80–99%) | W 1 chorobie |
| KIFBPkinesin family binding protein | Bardzo często (80–99%) | W 1 chorobie |
| LARGE1LARGE xylosyl- and glucuronyltransferase 1 | Bardzo często (80–99%) | W 1 chorobie |
| LEMD3LEM domain containing 3 | Bardzo często (80–99%) | W 1 chorobie |
| LTBP4latent transforming growth factor beta binding protein 4 | Bardzo często (80–99%) | W 1 chorobie |
| MAGEL2MAGE family member L2 | Bardzo często (80–99%) | W 5 chorobach |
| MAN2B1mannosidase alpha class 2B member 1 | Bardzo często (80–99%) | W 1 chorobie |
| MAP2K2mitogen-activated protein kinase kinase 2 | Bardzo często (80–99%) | W 1 chorobie |
| MBTPS2membrane bound transcription factor peptidase, site 2 | Bardzo często (80–99%) | W 1 chorobie |
| MKRN3makorin ring finger protein 3 | Bardzo często (80–99%) | W 1 chorobie |
| MYO5Amyosin VA | Bardzo często (80–99%) | W 1 chorobie |
| NF1neurofibromin 1 | Bardzo często (80–99%) | W 5 chorobach |
| NPAP1nuclear pore associated protein 1 | Bardzo często (80–99%) | W 1 chorobie |
| NSD1nuclear receptor binding SET domain protein 1 | Bardzo często (80–99%) | W 1 chorobie |
| PIEZO2piezo type mechanosensitive ion channel component 2 | Bardzo często (80–99%) | W 1 chorobie |
Pokaż jeszcze 258 genów
| Gen | Jak często występuje | Choroby |
|---|---|---|
| POMGNT1protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) | Bardzo często (80–99%) | W 1 chorobie |
| POMGNT2protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-) | Bardzo często (80–99%) | W 1 chorobie |
| POMKprotein O-mannose kinase | Bardzo często (80–99%) | W 1 chorobie |
| POMT1protein O-mannosyltransferase 1 | Bardzo często (80–99%) | W 1 chorobie |
| POMT2protein O-mannosyltransferase 2 | Bardzo często (80–99%) | W 2 chorobach |
| PRNPprion protein (Kanno blood group) | Bardzo często (80–99%) | W 1 chorobie |
| PTDSS1phosphatidylserine synthase 1 | Bardzo często (80–99%) | W 1 chorobie |
| PWAR1Prader Willi/Angelman region RNA 1 | Bardzo często (80–99%) | W 1 chorobie |
| PWRN1Prader-Willi region non-protein coding RNA 1 | Bardzo często (80–99%) | W 1 chorobie |
| RNU4ATACRNA, U4atac small nuclear | Bardzo często (80–99%) | W 1 chorobie |
| RXYLT1ribitol xylosyltransferase 1 | Bardzo często (80–99%) | W 1 chorobie |
| SC5Dsterol-C5-desaturase | Bardzo często (80–99%) | W 1 chorobie |
| SIL1SIL1 nucleotide exchange factor | Bardzo często (80–99%) | W 1 chorobie |
| SMAD4SMAD family member 4 | Bardzo często (80–99%) | W 1 chorobie |
| SMARCA2SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2 | Bardzo często (80–99%) | W 1 chorobie |
| SNORD115-1small nucleolar RNA, C/D box 115-1 | Bardzo często (80–99%) | W 1 chorobie |
| SNORD116-1small nucleolar RNA, C/D box 116-1 | Bardzo często (80–99%) | W 1 chorobie |
| SPG11SPG11 vesicle trafficking associated, spatacsin | Bardzo często (80–99%) | W 2 chorobach |
| SYN1synapsin I | Bardzo często (80–99%) | W 2 chorobach |
| TCF4transcription factor 4 | Bardzo często (80–99%) | W 1 chorobie |
| TCTN3tectonic family member 3 | Bardzo często (80–99%) | W 1 chorobie |
| UBE3Bubiquitin protein ligase E3B | Bardzo często (80–99%) | W 1 chorobie |
| YY1AP1YY1 associated protein 1 | Bardzo często (80–99%) | W 1 chorobie |
| ABCD1ATP binding cassette subfamily D member 1 | Często (30–79%) | W 1 chorobie |
| ADGRG1adhesion G protein-coupled receptor G1 | Często (30–79%) | W 1 chorobie |
| AFF2ALF transcription elongation factor 2 | Często (30–79%) | W 1 chorobie |
| ALMS1ALMS1 centrosome and basal body associated protein | Często (30–79%) | W 1 chorobie |
| AMACRalpha-methylacyl-CoA racemase | Często (30–79%) | W 1 chorobie |
| ARL6ARF like GTPase 6 | Często (30–79%) | W 2 chorobach |
| ARVCFARVCF delta catenin family member | Często (30–79%) | W 1 chorobie |
| ASLargininosuccinate lyase | Często (30–79%) | W 1 chorobie |
| ASPAaspartoacylase | Często (30–79%) | W 1 chorobie |
| AUTS2activator of transcription and developmental regulator AUTS2 | Często (30–79%) | W 1 chorobie |
| BBIP1BBSome interacting protein 1 | Często (30–79%) | W 1 chorobie |
| BBS1Bardet-Biedl syndrome 1 | Często (30–79%) | W 2 chorobach |
| BBS10Bardet-Biedl syndrome 10 | Często (30–79%) | W 1 chorobie |
| BBS12Bardet-Biedl syndrome 12 | Często (30–79%) | W 1 chorobie |
| BBS2Bardet-Biedl syndrome 2 | Często (30–79%) | W 1 chorobie |
| BBS4Bardet-Biedl syndrome 4 | Często (30–79%) | W 1 chorobie |
| BBS5Bardet-Biedl syndrome 5 | Często (30–79%) | W 1 chorobie |
| BBS7Bardet-Biedl syndrome 7 | Często (30–79%) | W 1 chorobie |
| BBS9Bardet-Biedl syndrome 9 | Często (30–79%) | W 1 chorobie |
| CBLIFcobalamin binding intrinsic factor | Często (30–79%) | W 1 chorobie |
| CDK4cyclin dependent kinase 4 | Często (30–79%) | W 1 chorobie |
| CDONcell adhesion associated, oncogene regulated | Często (30–79%) | W 5 chorobach |
| CEP19centrosomal protein 19 | Często (30–79%) | W 1 chorobie |
| CEP290centrosomal protein 290 | Często (30–79%) | W 1 chorobie |
| CFAP418cilia and flagella associated protein 418 | Często (30–79%) | W 1 chorobie |
| CLTCL1clathrin heavy chain like 1 | Często (30–79%) | W 1 chorobie |
| COMTcatechol-O-methyltransferase | Często (30–79%) | W 1 chorobie |
| CRIPTOcripto, EGF-CFC family member | Często (30–79%) | W 5 chorobach |
| CYP27A1cytochrome P450 family 27 subfamily A member 1 | Często (30–79%) | W 1 chorobie |
| DISP1dispatched RND transporter family member 1 | Często (30–79%) | W 5 chorobach |
| DLL1delta like canonical Notch ligand 1 | Często (30–79%) | W 5 chorobach |
| DPP9dipeptidyl peptidase 9 | Często (30–79%) | W 1 chorobie |
| DPYDdihydropyrimidine dehydrogenase | Często (30–79%) | W 1 chorobie |
| EXTL3exostosin like glycosyltransferase 3 | Często (30–79%) | W 1 chorobie |
| FANCFFA complementation group F | Często (30–79%) | W 1 chorobie |
| FGF8fibroblast growth factor 8 | Często (30–79%) | W 5 chorobach |
| FGFR1fibroblast growth factor receptor 1 | Często (30–79%) | W 2 chorobach |
| FIBPFGF1 intracellular binding protein | Często (30–79%) | W 1 chorobie |
| FOXH1forkhead box H1 | Często (30–79%) | W 5 chorobach |
| FOXP2forkhead box P2 | Często (30–79%) | W 1 chorobie |
| FSD1Lfibronectin type III and SPRY domain containing 1 like | Często (30–79%) | W 1 chorobie |
| GALTgalactose-1-phosphate uridylyltransferase | Często (30–79%) | W 1 chorobie |
| GAS1growth arrest specific 1 | Często (30–79%) | W 5 chorobach |
| GDI1GDP dissociation inhibitor 1 | Często (30–79%) | W 1 chorobie |
| GLI2GLI family zinc finger 2 | Często (30–79%) | W 5 chorobach |
| GLUD1glutamate dehydrogenase 1 | Często (30–79%) | W 1 chorobie |
| GP1BBglycoprotein Ib platelet subunit beta | Często (30–79%) | W 1 chorobie |
| GRIA3glutamate ionotropic receptor AMPA type subunit 3 | Często (30–79%) | W 1 chorobie |
| GRIN2Aglutamate ionotropic receptor NMDA type subunit 2A | Często (30–79%) | W 3 chorobach |
| HIRAhistone cell cycle regulator | Często (30–79%) | W 1 chorobie |
| IFNGinterferon gamma | Często (30–79%) | W 2 chorobach |
| IFT172intraflagellar transport 172 | Często (30–79%) | W 1 chorobie |
| IFT27intraflagellar transport 27 | Często (30–79%) | W 1 chorobie |
| IFT74intraflagellar transport 74 | Często (30–79%) | W 1 chorobie |
| JMJD1Cjumonji domain containing 1C | Często (30–79%) | W 1 chorobie |
| KIF11kinesin family member 11 | Często (30–79%) | W 1 chorobie |
| LAMP2lysosome associated membrane protein 2 | Często (30–79%) | W 1 chorobie |
| LTBP1latent transforming growth factor beta binding protein 1 | Często (30–79%) | W 1 chorobie |
| LZTFL1leucine zipper transcription factor like 1 | Często (30–79%) | W 1 chorobie |
| MAU2MAU2 sister chromatid cohesion factor | Często (30–79%) | W 1 chorobie |
| MED13Lmediator complex subunit 13L | Często (30–79%) | W 1 chorobie |
| MID1midline 1 | Często (30–79%) | W 1 chorobie |
| MKKSMKKS centrosomal shuttling protein | Często (30–79%) | W 1 chorobie |
| MKS1MKS transition zone complex subunit 1 | Często (30–79%) | W 1 chorobie |
| MORC2MORC family CW-type zinc finger 2 | Często (30–79%) | W 1 chorobie |
| MT-CO1mitochondrially encoded cytochrome c oxidase I | Często (30–79%) | W 1 chorobie |
| MT-CO2mitochondrially encoded cytochrome c oxidase II | Często (30–79%) | W 1 chorobie |
| MT-CO3mitochondrially encoded cytochrome c oxidase III | Często (30–79%) | W 1 chorobie |
| MT-ND1mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 | Często (30–79%) | W 1 chorobie |
| MT-ND4mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 | Często (30–79%) | W 1 chorobie |
| MT-ND5mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 | Często (30–79%) | W 1 chorobie |
| MT-ND6mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 | Często (30–79%) | W 1 chorobie |
| MT-TFmitochondrially encoded tRNA-Phe (UUU/C) | Często (30–79%) | W 1 chorobie |
| MT-THmitochondrially encoded tRNA-His (CAU/C) | Często (30–79%) | W 1 chorobie |
| MT-TL1mitochondrially encoded tRNA-Leu (UUA/G) 1 | Często (30–79%) | W 1 chorobie |
| MT-TQmitochondrially encoded tRNA-Gln (CAA/G) | Często (30–79%) | W 1 chorobie |
| MT-TS1mitochondrially encoded tRNA-Ser (UCN) 1 | Często (30–79%) | W 1 chorobie |
| MT-TS2mitochondrially encoded tRNA-Ser (AGU/C) 2 | Często (30–79%) | W 1 chorobie |
| MT-TWmitochondrially encoded tRNA-Trp (UGA/G) | Często (30–79%) | W 1 chorobie |
| MTORmechanistic target of rapamycin kinase | Często (30–79%) | W 1 chorobie |
| MYCNMYCN proto-oncogene, bHLH transcription factor | Często (30–79%) | W 2 chorobach |
| MYT1Lmyelin transcription factor 1 like | Często (30–79%) | W 1 chorobie |
| NDNnecdin, MAGE family member | Często (30–79%) | W 3 chorobach |
| NODALnodal growth differentiation factor | Często (30–79%) | W 5 chorobach |
| NPHP1nephrocystin 1 | Często (30–79%) | W 1 chorobie |
| NTRK1neurotrophic receptor tyrosine kinase 1 | Często (30–79%) | W 1 chorobie |
| OCA2OCA2 melanosomal transmembrane protein | Często (30–79%) | W 3 chorobach |
| PI4KAphosphatidylinositol 4-kinase alpha | Często (30–79%) | W 1 chorobie |
| PIK3C2Aphosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha | Często (30–79%) | W 1 chorobie |
| PLCH1phospholipase C eta 1 | Często (30–79%) | W 1 chorobie |
| PRKD1protein kinase D1 | Często (30–79%) | W 1 chorobie |
| PRMT7protein arginine methyltransferase 7 | Często (30–79%) | W 1 chorobie |
| PTCH1patched 1 | Często (30–79%) | W 5 chorobach |
| RDH11retinol dehydrogenase 11 | Często (30–79%) | W 1 chorobie |
| RNF168ring finger protein 168 | Często (30–79%) | W 1 chorobie |
| RPS23ribosomal protein S23 | Często (30–79%) | W 1 chorobie |
| RREB1ras responsive element binding protein 1 | Często (30–79%) | W 1 chorobie |
| SCAPERS-phase cyclin A associated protein in the ER | Często (30–79%) | W 1 chorobie |
| SCLT1sodium channel and clathrin linker 1 | Często (30–79%) | W 1 chorobie |
| SDCCAG8SHH signaling and ciliogenesis regulator SDCCAG8 | Często (30–79%) | W 1 chorobie |
| SEC24CSEC24 homolog C, COPII component | Często (30–79%) | W 1 chorobie |
| SH2B1SH2B adaptor protein 1 | Często (30–79%) | W 1 chorobie |
| SHHsonic hedgehog signaling molecule | Często (30–79%) | W 6 chorobach |
| SIM1SIM bHLH transcription factor 1 | Często (30–79%) | W 2 chorobach |
| SIX3SIX homeobox 3 | Często (30–79%) | W 5 chorobach |
| SLC25A15solute carrier family 25 member 15 | Często (30–79%) | W 2 chorobach |
| SMC1Astructural maintenance of chromosomes 1A | Często (30–79%) | W 1 chorobie |
| SNRPNsmall nuclear ribonucleoprotein polypeptide N | Często (30–79%) | W 3 chorobach |
| SPARTspartin | Często (30–79%) | W 1 chorobie |
| SPRED1sprouty related EVH1 domain containing 1 | Często (30–79%) | W 2 chorobach |
| SRPX2sushi repeat containing protein X-linked 2 | Często (30–79%) | W 3 chorobach |
| STAG2STAG2 cohesin complex component | Często (30–79%) | W 2 chorobach |
| STILSTIL centriolar assembly protein | Często (30–79%) | W 5 chorobach |
| TBX1T-box transcription factor 1 | Często (30–79%) | W 3 chorobach |
| TGIF1TGFB induced factor homeobox 1 | Często (30–79%) | W 5 chorobach |
| THRBthyroid hormone receptor beta | Często (30–79%) | W 1 chorobie |
| TRIM32tripartite motif containing 32 | Często (30–79%) | W 1 chorobie |
| TSC1TSC complex subunit 1 | Często (30–79%) | W 2 chorobach |
| TSC2TSC complex subunit 2 | Często (30–79%) | W 2 chorobach |
| TTC8tetratricopeptide repeat domain 8 | Często (30–79%) | W 1 chorobie |
| UFD1ubiquitin recognition factor in ER associated degradation 1 | Często (30–79%) | W 1 chorobie |
| WASWASP actin nucleation promoting factor | Często (30–79%) | W 1 chorobie |
| WDPCPWD repeat containing planar cell polarity effector | Często (30–79%) | W 1 chorobie |
| ZIC2Zic family zinc finger 2 | Często (30–79%) | W 5 chorobach |
| ALDOAaldolase, fructose-bisphosphate A | Czasami (5–29%) | W 1 chorobie |
| ALPK3alpha kinase 3 | Czasami (5–29%) | W 1 chorobie |
| AMER1APC membrane recruitment protein 1 | Czasami (5–29%) | W 1 chorobie |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Czasami (5–29%) | W 1 chorobie |
| CA2carbonic anhydrase 2 | Czasami (5–29%) | W 1 chorobie |
| CACNA1Hcalcium voltage-gated channel subunit alpha1 H | Czasami (5–29%) | W 1 chorobie |
| CBLCbl proto-oncogene | Czasami (5–29%) | W 1 chorobie |
| CBScystathionine beta-synthase | Czasami (5–29%) | W 1 chorobie |
| CDC45cell division cycle 45 | Czasami (5–29%) | W 1 chorobie |
| CDC6cell division cycle 6 | Czasami (5–29%) | W 1 chorobie |
| CDT1chromatin licensing and DNA replication factor 1 | Czasami (5–29%) | W 1 chorobie |
| CHRNA7cholinergic receptor nicotinic alpha 7 subunit | Czasami (5–29%) | W 1 chorobie |
| CHSY1chondroitin sulfate synthase 1 | Czasami (5–29%) | W 1 chorobie |
| COX7Bcytochrome c oxidase subunit 7B | Czasami (5–29%) | W 1 chorobie |
| CTNNB1catenin beta 1 | Czasami (5–29%) | W 1 chorobie |
| DARS2aspartyl-tRNA synthetase 2, mitochondrial | Czasami (5–29%) | W 1 chorobie |
| DCCDCC netrin 1 receptor | Czasami (5–29%) | W 1 chorobie |
| DNAL4dynein axonemal light chain 4 | Czasami (5–29%) | W 1 chorobie |
| DTNAdystrobrevin alpha | Czasami (5–29%) | W 1 chorobie |
| DVL1dishevelled segment polarity protein 1 | Czasami (5–29%) | W 1 chorobie |
| DVL3dishevelled segment polarity protein 3 | Czasami (5–29%) | W 1 chorobie |
| EFHC1EF-hand domain containing 1 | Czasami (5–29%) | W 1 chorobie |
| EIF4A3eukaryotic translation initiation factor 4A3 | Czasami (5–29%) | W 1 chorobie |
| FBXW7F-box and WD repeat domain containing 7 | Czasami (5–29%) | W 1 chorobie |
| FLT4fms related receptor tyrosine kinase 4 | Czasami (5–29%) | W 1 chorobie |
| FZD2frizzled class receptor 2 | Czasami (5–29%) | W 1 chorobie |
| GABRA1gamma-aminobutyric acid type A receptor subunit alpha1 | Czasami (5–29%) | W 1 chorobie |
| GABRB3gamma-aminobutyric acid type A receptor subunit beta3 | Czasami (5–29%) | W 1 chorobie |
| GABRG2gamma-aminobutyric acid type A receptor subunit gamma2 | Czasami (5–29%) | W 2 chorobach |
| GMNNgeminin DNA replication inhibitor | Czasami (5–29%) | W 1 chorobie |
| GRB10growth factor receptor bound protein 10 | Czasami (5–29%) | W 1 chorobie |
| H19H19 imprinted maternally expressed transcript | Czasami (5–29%) | W 1 chorobie |
| HCCSholocytochrome c synthase | Czasami (5–29%) | W 1 chorobie |
| HDAC8histone deacetylase 8 | Czasami (5–29%) | W 1 chorobie |
| HPD4-hydroxyphenylpyruvate dioxygenase | Czasami (5–29%) | W 1 chorobie |
| IGF2insulin like growth factor 2 | Czasami (5–29%) | W 1 chorobie |
| IKBKGinhibitor of nuclear factor kappa B kinase regulatory subunit gamma | Czasami (5–29%) | W 1 chorobie |
| IRF6interferon regulatory factor 6 | Czasami (5–29%) | W 2 chorobach |
| JRKJrk helix-turn-helix protein | Czasami (5–29%) | W 1 chorobie |
| KCNA1potassium voltage-gated channel subfamily A member 1 | Czasami (5–29%) | W 1 chorobie |
| KCNJ2potassium inwardly rectifying channel subfamily J member 2 | Czasami (5–29%) | W 2 chorobach |
| KCNJ5potassium inwardly rectifying channel subfamily J member 5 | Czasami (5–29%) | W 1 chorobie |
| KDM2Blysine demethylase 2B | Czasami (5–29%) | W 1 chorobie |
| KLF13KLF transcription factor 13 | Czasami (5–29%) | W 1 chorobie |
| KRASKRas proto-oncogene, GTPase | Czasami (5–29%) | W 1 chorobie |
| LAS1LLAS1 like ribosome biogenesis factor | Czasami (5–29%) | W 1 chorobie |
| LYSTlysosomal trafficking regulator | Czasami (5–29%) | W 1 chorobie |
| LZTR1leucine zipper like post translational regulator 1 | Czasami (5–29%) | W 1 chorobie |
| MRASmuscle RAS oncogene homolog | Czasami (5–29%) | W 1 chorobie |
| MTHFRmethylenetetrahydrofolate reductase | Czasami (5–29%) | W 1 chorobie |
| NDUFB11NADH:ubiquinone oxidoreductase subunit B11 | Czasami (5–29%) | W 1 chorobie |
| NRASNRAS proto-oncogene, GTPase | Czasami (5–29%) | W 1 chorobie |
| NTN1netrin 1 | Czasami (5–29%) | W 1 chorobie |
| ORC1origin recognition complex subunit 1 | Czasami (5–29%) | W 1 chorobie |
| ORC4origin recognition complex subunit 4 | Czasami (5–29%) | W 1 chorobie |
| ORC6origin recognition complex subunit 6 | Czasami (5–29%) | W 1 chorobie |
| OTCornithine transcarbamylase | Czasami (5–29%) | W 1 chorobie |
| PRRT2proline rich transmembrane protein 2 | Czasami (5–29%) | W 1 chorobie |
| PTPN11protein tyrosine phosphatase non-receptor type 11 | Czasami (5–29%) | W 1 chorobie |
| RAD51RAD51 recombinase | Czasami (5–29%) | W 1 chorobie |
| RAF1Raf-1 proto-oncogene, serine/threonine kinase | Czasami (5–29%) | W 1 chorobie |
| RASA2RAS p21 protein activator 2 | Czasami (5–29%) | W 1 chorobie |
| RIT1Ras like without CAAX 1 | Czasami (5–29%) | W 1 chorobie |
| RRASRAS related | Czasami (5–29%) | W 1 chorobie |
| RRAS2RAS related 2 | Czasami (5–29%) | W 1 chorobie |
| SBF2SET binding factor 2 | Czasami (5–29%) | W 1 chorobie |
| SLC2A1solute carrier family 2 member 1 | Czasami (5–29%) | W 2 chorobach |
| SLC2A10solute carrier family 2 member 10 | Czasami (5–29%) | W 1 chorobie |
| SOS1SOS Ras/Rac guanine nucleotide exchange factor 1 | Czasami (5–29%) | W 1 chorobie |
| SOS2SOS Ras/Rho guanine nucleotide exchange factor 2 | Czasami (5–29%) | W 1 chorobie |
| SPRED2sprouty related EVH1 domain containing 2 | Czasami (5–29%) | W 1 chorobie |
| SUGCTsuccinyl-CoA:glutarate-CoA transferase | Czasami (5–29%) | W 1 chorobie |
| THOC6THO complex subunit 6 | Czasami (5–29%) | W 1 chorobie |
| TMEM63Atransmembrane protein 63A | Czasami (5–29%) | W 1 chorobie |
| TRIOtrio Rho guanine nucleotide exchange factor | Czasami (5–29%) | W 1 chorobie |
| TUBB3tubulin beta 3 class III | Czasami (5–29%) | W 1 chorobie |
| WNT5AWnt family member 5A | Czasami (5–29%) | W 1 chorobie |
| ZFYVE26zinc finger FYVE-type containing 26 | Czasami (5–29%) | W 1 chorobie |
| HALhistidine ammonia-lyase | Rzadko (1–4%) | W 1 chorobie |
| HINT1histidine triad nucleotide binding protein 1 | Rzadko (1–4%) | W 1 chorobie |
| MSX1msh homeobox 1 | Rzadko (1–4%) | W 1 chorobie |
| NECTIN1nectin cell adhesion molecule 1 | Rzadko (1–4%) | W 1 chorobie |
| SMPD1sphingomyelin phosphodiesterase 1 | Rzadko (1–4%) | W 1 chorobie |
| SPG7SPG7 matrix AAA peptidase subunit, paraplegin | Rzadko (1–4%) | W 1 chorobie |
| TAF11TATA-box binding protein associated factor 11 | Rzadko (1–4%) | W 1 chorobie |
| TP63tumor protein p63 | Rzadko (1–4%) | W 1 chorobie |
| ALDH18A1aldehyde dehydrogenase 18 family member A1 | Nie odnotowano | W 1 chorobie |
| APTXaprataxin | Nie odnotowano | W 1 chorobie |
| ARXaristaless related homeobox | Nie odnotowano | W 1 chorobie |
| BLMBLM RecQ like helicase | Nie odnotowano | W 1 chorobie |
| CCDC28Bcoiled-coil domain containing 28B | Nie odnotowano | W 1 chorobie |
| COQ2coenzyme Q2, polyprenyltransferase | Nie odnotowano | W 1 chorobie |
| DGCR2DiGeorge syndrome critical region gene 2 | Nie odnotowano | W 1 chorobie |
| DGCR6DiGeorge syndrome critical region gene 6 | Nie odnotowano | W 1 chorobie |
| DGCR8DGCR8 microprocessor complex subunit | Nie odnotowano | W 1 chorobie |
| DNAJC21DnaJ heat shock protein family (Hsp40) member C21 | Nie odnotowano | W 1 chorobie |
| ESS2ess-2 spliceosome associated protein | Nie odnotowano | W 1 chorobie |
| GNPTABN-acetylglucosamine-1-phosphate transferase subunits alpha and beta | Nie odnotowano | W 1 chorobie |
| JAG1jagged canonical Notch ligand 1 | Nie odnotowano | W 1 chorobie |
| PIGHphosphatidylinositol glycan anchor biosynthesis class H | Nie odnotowano | W 1 chorobie |
| SBDSSBDS ribosome maturation factor | Nie odnotowano | W 1 chorobie |
| SIX6SIX homeobox 6 | Nie odnotowano | W 1 chorobie |
| SOX2SRY-box transcription factor 2 | Nie odnotowano | W 1 chorobie |
| SRP54signal recognition particle 54 | Nie odnotowano | W 1 chorobie |
| TERCtelomerase RNA component | Nie odnotowano | W 1 chorobie |
| TERTtelomerase reverse transcriptase | Nie odnotowano | W 1 chorobie |
| TINF2TERF1 interacting nuclear factor 2 | Nie odnotowano | W 1 chorobie |
| TUBB2Btubulin beta 2B class IIb | Nie odnotowano | W 1 chorobie |
| TUBB4Atubulin beta 4A class IVa | Nie odnotowano | W 1 chorobie |
| TWNKtwinkle mtDNA helicase | Nie odnotowano | W 1 chorobie |
| WDR1WD repeat domain 1 | Nie odnotowano | W 1 chorobie |
Jak często występuje wśród osób z jedną z chorób związanych z tym genem, najczęściej spośród wszystkich, według danych Human Phenotype Ontology. Te strony opisują cechy i badania, na których się opierają; nie są diagnozą, a w sprawie objawów należy zwrócić się do lekarza lub doradcy genetycznego.
Cechy podrzędne
Cechy nadrzędne
Skąd pochodzą te dane
- Human Phenotype Ontology, wydanie 2026-09-01: cecha, jej nazwy, definicja oraz geny z nią powiązane. Więcej informacji znajdą Państwo na stronie hpo.jax.org.
- Wydanie danych 2026.10.16-c6eea6bf.
Jeden test. Odpowiedzi na całe życie.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni